HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin.

AbstractBACKGROUND:
Inulin and oligofructose promote selective growth of saccharolytic bacteria with low inflammatory potential.
OBJECTIVE:
To test the effect of oligofructose-enriched inulin in patients with active ulcerative colitis.
DESIGN:
Prospective, randomized, placebo controlled pilot trial. Eligible patients had been previously in remission with mesalazine as maintenance therapy or no drug, and presented with a relapse of mild to moderate activity. They were treated with mesalazine (3 g/day) and randomly allocated to receive either oligofructose-enriched inulin (12 g/day, p.o., n = 10) or placebo (12 g/day of maltodextrin, p.o., n = 9) for 2 week. Primary endpoint was the anti-inflammatory effect as determined by reduction of calprotectin and human DNA in faeces.
RESULTS:
Rachmilewitz score decreased in both groups, reaching statistical significance at day 14 (P < 0.05). Oligofructose-enriched inulin was well-tolerated and dyspeptic symptoms scale decreased significantly with active treatment but not with placebo. At day 7, an early significant reduction of calprotectin was observed in the group receiving oligofructose-enriched inulin (day 0: 4377 +/- 659 microg/g; day 7: 1033 +/- 393 microg/g, P < 0.05) but not in the placebo group (day 0: 5834 +/- 1563 microg/g; day 7: 4084 +/- 1395 microg/g, n.s.). Changes in faecal concentration of human DNA were not significant.
CONCLUSION:
In active ulcerative colitis, dietary supplementation with oligofructose-enriched inulin is well tolerated and is associated with early reduction in faecal calprotectin.
AuthorsF Casellas, N Borruel, A Torrejón, E Varela, M Antolin, F Guarner, J-R Malagelada
JournalAlimentary pharmacology & therapeutics (Aliment Pharmacol Ther) Vol. 25 Issue 9 Pg. 1061-7 (May 01 2007) ISSN: 0269-2813 [Print] England
PMID17439507 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Drug Combinations
  • Gastrointestinal Agents
  • Leukocyte L1 Antigen Complex
  • Oligosaccharides
  • oligofructose
  • Inulin
Topics
  • Adolescent
  • Adult
  • Aged
  • Colitis, Ulcerative (diet therapy, metabolism)
  • Double-Blind Method
  • Drug Combinations
  • Feces (chemistry)
  • Female
  • Gastrointestinal Agents (administration & dosage)
  • Humans
  • Inulin (administration & dosage)
  • Leukocyte L1 Antigen Complex (metabolism)
  • Male
  • Middle Aged
  • Oligosaccharides (administration & dosage)
  • Pilot Projects

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: